6.
Reddy V, Anter E, Rackauskas G, Peichl P, Koruth J, Petru J
. Lattice-Tip Focal Ablation Catheter That Toggles Between Radiofrequency and Pulsed Field Energy to Treat Atrial Fibrillation: A First-in-Human Trial. Circ Arrhythm Electrophysiol. 2020; 13(6):e008718.
DOI: 10.1161/CIRCEP.120.008718.
View
7.
Pishvaian M, Blais E, Brody J, Lyons E, DeArbeloa P, Hendifar A
. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. Lancet Oncol. 2020; 21(4):508-518.
PMC: 7453743.
DOI: 10.1016/S1470-2045(20)30074-7.
View
8.
Park W, Chawla A, OReilly E
. Pancreatic Cancer: A Review. JAMA. 2021; 326(9):851-862.
PMC: 9363152.
DOI: 10.1001/jama.2021.13027.
View
9.
Zhang X, Zhang X, Ding X, Wang Z, Fan Y, Chen G
. Novel irreversible electroporation ablation (Nano-knife) versus radiofrequency ablation for the treatment of solid liver tumors: a comparative, randomized, multicenter clinical study. Front Oncol. 2022; 12:945123.
PMC: 9557230.
DOI: 10.3389/fonc.2022.945123.
View
10.
Runas K, Malmstadt N
. Low levels of lipid oxidation radically increase the passive permeability of lipid bilayers. Soft Matter. 2014; 11(3):499-505.
PMC: 4477792.
DOI: 10.1039/c4sm01478b.
View
11.
Aycock K, Vadlamani R, Jacobs E, Imran K, Verbridge S, Allen I
. Experimental and Numerical Investigation of Parameters Affecting High-Frequency Irreversible Electroporation for Prostate Cancer Ablation. J Biomech Eng. 2022; 144(6).
DOI: 10.1115/1.4053595.
View
12.
Ricke J, Jurgens J, Deschamps F, Tselikas L, Uhde K, Kosiek O
. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial. Cardiovasc Intervent Radiol. 2015; 38(2):401-8.
DOI: 10.1007/s00270-014-1049-0.
View
13.
Vernier P, Levine Z, Wu Y, Joubert V, Ziegler M, Mir L
. Electroporating fields target oxidatively damaged areas in the cell membrane. PLoS One. 2009; 4(11):e7966.
PMC: 2779261.
DOI: 10.1371/journal.pone.0007966.
View
14.
Timmer F, Geboers B, Ruarus A, Vroomen L, Schouten E, van der Lei S
. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2024; 9(5):448-459.
DOI: 10.1016/S2468-1253(24)00017-7.
View
15.
Akinwande O, Ahmad S, Van Meter T, Schulz B, Martin R
. CT Findings of Patients Treated with Irreversible Electroporation for Locally Advanced Pancreatic Cancer. J Oncol. 2015; 2015:680319.
PMC: 4651710.
DOI: 10.1155/2015/680319.
View
16.
Alex A, Piano V, Polley S, Stuiver M, Voss S, Ciossani G
. Electroporated recombinant proteins as tools for in vivo functional complementation, imaging and chemical biology. Elife. 2019; 8.
PMC: 6656429.
DOI: 10.7554/eLife.48287.
View
17.
Siddiqui I, Latouche E, DeWitt M, Swet J, Kirks R, Baker E
. Induction of rapid, reproducible hepatic ablations using next-generation, high frequency irreversible electroporation (H-FIRE) in vivo. HPB (Oxford). 2016; 18(9):726-34.
PMC: 5011100.
DOI: 10.1016/j.hpb.2016.06.015.
View
18.
Stacey M, Fox P, Buescher S, Kolb J
. Nanosecond pulsed electric field induced cytoskeleton, nuclear membrane and telomere damage adversely impact cell survival. Bioelectrochemistry. 2011; 82(2):131-4.
DOI: 10.1016/j.bioelechem.2011.06.002.
View
19.
Shao Q, OFlanagan S, Lam T, Roy P, Pelaez F, Burbach B
. Engineering T cell response to cancer antigens by choice of focal therapeutic conditions. Int J Hyperthermia. 2019; 36(1):130-138.
DOI: 10.1080/02656736.2018.1539253.
View
20.
Rems L, Viano M, Kasimova M, Miklavcic D, Tarek M
. The contribution of lipid peroxidation to membrane permeability in electropermeabilization: A molecular dynamics study. Bioelectrochemistry. 2018; 125:46-57.
DOI: 10.1016/j.bioelechem.2018.07.018.
View